Author:
O’Brien Martin J.,Shu Qiang,Stinson W.Alexander,Tsou Pei-Suen,Ruth Jeffrey H.,Isozaki Takeo,Campbell Phillip L.,Ohara Ray A.,Koch Alisa E.,Fox David A.,Amin M. Asif
Funder
U.S. Department of Defense
Shenzhen science and technology research and development funds
Shandong Provincial Natural Science Foundation, China
The Scleroderma Foundation, and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Barondes SH, Cooper DN, Gitt MA, Leffler H. Galectins: structure and function of a large family of animal lectins. J Biol Chem. 1994;269(33):20807–10.
2. Heusschen R, Griffioen AW, Thijssen VL. Galectin-9 in tumor biology: a jack of multiple trades. Biochim Biophys Acta. 2013;1836(1):177–85.
3. Heusschen R, Schulkens IA, van Beijnum J, Griffioen AW, Thijssen VL. Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis. Biochim Biophys Acta. 2014;1842(2):284–92.
4. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6(12):1245–52.
5. Oomizu S, Arikawa T, Niki T, Kadowaki T, Ueno M, Nishi N, et al. Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion. PLoS One. 2012;7(11):e48574.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献